Healthcare

BTC Health Ltd (ASX:BTC) announced in September 2026 that Arna Pharma, one of its healthcare investments, had entered voluntary administration. The disclosure followed the company's FY2026 results and was released alongside a routine NTA backing update. The available source material confirms the administration itself …

• His brief includes US federal healthcare, veterans’ health and research partnerships.

• TIBA can be used for commercial batch release and stability monitoring.

On 25 September 2026, Microba Life Sciences disclosed that Dr Luke Reid, its CEO, is on medical leave. To maintainLeadershipcontinuity, the Board appointed experienced executive Mr Geoffrey Cockerill as Interim CEO, commencing 29 September 2026. Cockerill brings more than 30 years of leadership experience …

On 25 September 2026, Healius announced the binding sale of Agilex Biolabs to Novotech, a leading clinical research organisation backed by TPG-affiliatedInvestmentfunds. The deal is valued at A$160 million enterprise value — equivalent to 19.8x Agilex Biolabs' FY2026 EBITDA on a pre-AASB16 basis (FY26 …

Anatara Lifesciences released its FY26 annual results via Appendix 4E, reporting a net loss after tax attributable to members of $933,230 for the year ended 30 June 2026 — a 52% reduction in the loss compared to the prior year (described as a decrease …

On 26 August 2026, Nova Eye Medical provided its audited financial statements for the year ended 30 June 2026. Full-year sales reached A$34.9 million — up 26% in constant currency on the prior year.Revenuefor H2 FY26 was A$18.2 million, generating the company's first EBITDA-positive …